BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 19345585)

  • 1. 148th ENMC international workshop on the scientific contributions of the EURALS consortium on amyotrophic lateral sclerosis.
    Beghi E; Pupillo E; Zoccolella S;
    Neuromuscul Disord; 2009 May; 19(5):379-81. PubMed ID: 19345585
    [No Abstract]   [Full Text] [Related]  

  • 2. 127th ENMC International Workshop: implementation of a European registry of ALS. Naarden, The Netherlands, 8-10 October 2004.
    Beghi E
    Neuromuscul Disord; 2006 Jan; 16(1):46-53. PubMed ID: 16376080
    [No Abstract]   [Full Text] [Related]  

  • 3. Amyotrophic lateral sclerosis: a consensus viewpoint on designing and implementing a clinical trial.
    Leigh PN; Swash M; Iwasaki Y; Ludolph A; Meininger V; Miller RG; Mitsumoto H; Shaw P; Tashiro K; Van Den Berg L
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Jun; 5(2):84-98. PubMed ID: 15204010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Data sharing statements for clinical trials: a requirement of the International Committee of Medical Journal Editors.
    Taichman DB; Sahni P; Pinborg A; Peiperl L; Laine C; James A; Hong ST; Haileamlak A; Gollogly L; Godlee F; Frizelle FA; Florenzano F; Drazen JM; Bauchner H; Baethge C; Backus J
    Bull World Health Organ; 2017 Jul; 95(7):482-483. PubMed ID: 28670009
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation and management of amyotrophic lateral sclerosis.
    Valadi N
    Prim Care; 2015 Jun; 42(2):177-87. PubMed ID: 25979579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical highlights. 17th International Symposium on ALS/MND Yokohama, Japan, November 30, 2006 through December 2, 2006.
    Mitsumoto H
    Amyotroph Lateral Scler; 2007 Apr; 8(2):119-20. PubMed ID: 17453641
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical Trials of Therapies for Amyotrophic Lateral Sclerosis: One Size Does Not Fit All.
    Goutman SA; Feldman EL
    JAMA Neurol; 2015 Jul; 72(7):743-4. PubMed ID: 25961436
    [No Abstract]   [Full Text] [Related]  

  • 8. North East ALS Study Group.
    Cudkowicz M; Shefner J
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():125-7. PubMed ID: 15512893
    [No Abstract]   [Full Text] [Related]  

  • 9. [Epidemiology and treatment of amyotrophic lateral sclerosis].
    Camu W
    Soins; 2008 Jun; (726):40-3. PubMed ID: 18697338
    [No Abstract]   [Full Text] [Related]  

  • 10. Guidelines in motor neurone disease (MND)/amyotrophic lateral sclerosis (ALS) - from diagnosis to patient care.
    Mitchell JD
    J Neurol; 2000 Dec; 247 Suppl 6():VI/7-12. PubMed ID: 19714406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. World Federation of Neurology Research Group on Neuromuscular Diseases Subcommittee on Motor Neuron Disease. Airlie House guidelines. Therapeutic trials in amyotrophic lateral sclerosis. Airlie House "Therapeutic Trials in ALS" Workshop Contributors.
    J Neurol Sci; 1995 May; 129 Suppl():1-10. PubMed ID: 7595596
    [No Abstract]   [Full Text] [Related]  

  • 12. 48th ENMC International Workshop: drug trials and clinical research in ALS. 12-14 January 1997, Naarden, The Netherlands.
    Vianney de Jong JM
    Neuromuscul Disord; 1997 Sep; 7(6-7):404-6. PubMed ID: 9327406
    [No Abstract]   [Full Text] [Related]  

  • 13. 151st ENMC international workshop: Inflammatory Neuropathy Consortium 13th-15th April 2007, Schiphol, The Netherlands.
    Lunn MP; Léger JM; Merkies IS; Van den Bergh P; van Schaik IN; ;
    Neuromuscul Disord; 2008 Jan; 18(1):85-9. PubMed ID: 17869518
    [No Abstract]   [Full Text] [Related]  

  • 14. Comment: Plateaus and reversals in ALS disease course or limitations of trial design?
    van Eijk RP; van den Berg LH
    Neurology; 2016 Mar; 86(9):811. PubMed ID: 26802092
    [No Abstract]   [Full Text] [Related]  

  • 15. Registration of trials in children: update of current international initiatives.
    Pandolfini C; Bonati M; Sammons HM
    Arch Dis Child; 2009 Sep; 94(9):717-9. PubMed ID: 19457883
    [No Abstract]   [Full Text] [Related]  

  • 16. 131st ENMC international workshop: selection of outcome measures for peripheral neuropathy clinical trials 10-12 December 2004, Naarden, The Netherlands.
    Merkies IS; Lauria G
    Neuromuscul Disord; 2006 Feb; 16(2):149-56. PubMed ID: 16431105
    [No Abstract]   [Full Text] [Related]  

  • 17. Predictors of delay in the diagnosis and clinical trial entry of amyotrophic lateral sclerosis patients: a population-based study.
    Zoccolella S; Beghi E; Palagano G; Fraddosio A; Samarelli V; Lamberti P; Lepore V; Serlenga L; Logroscino G;
    J Neurol Sci; 2006 Dec; 250(1-2):45-9. PubMed ID: 16920152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 145th ENMC International Workshop: planning for an International Trial of Steroid Dosage Regimes in DMD (FOR DMD), 22-24th October 2006, Naarden, The Netherlands.
    Bushby K; Griggs R;
    Neuromuscul Disord; 2007 May; 17(5):423-8. PubMed ID: 17433676
    [No Abstract]   [Full Text] [Related]  

  • 19. [Japanese Consortium for Amyotrophic Lateral Sclerosis research (JaCALS)].
    Atsuta N; Nakamura R; Watanabe H; Sobue G
    Brain Nerve; 2014 Sep; 66(9):1090-6. PubMed ID: 25200580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-self-sufficiency as a primary outcome measure in ALS trials.
    Marin B; Bianchi E; Pupillo E; Lunetta C; Tremolizzo L; Logroscino G; Chiò A; Preux PM; Beghi E
    Amyotroph Lateral Scler Frontotemporal Degener; 2015; 17(1-2):77-84. PubMed ID: 26470831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.